Presented by The Johns Hopkins University School of Medicine
Course Directors: Srinivasa N. Raja, MD and Paul J. Christo, MD
This course is designed to provide Pain Specialists and Primary Care Providers an evidence-based update of the pharmacological and interventional techniques for managing chronic pain.
Topics & Speakers
Target Audience
- Pain Specialists
- Anesthesiologists
- Pain Management Consultants
- Primary Care Providers
- Family Practitioners
- Internists
- Nurse Practitioners
- Physician Assistant
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 10.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA category 1 credit.
| Credits |
10.5 AMA PRA Category 1 Credits™ |
| Release Date |
January 11, 2006 |
| Expire Date |
January 11, 2009 |
CME credit is obtained upon successful completion of a self-assessment examination. A $30 processing fee must accompany the completed program evaluation.
Learning Objectives
At the conclusion of this course, participants should be able to:
- Develop a diagnostic algorithm for managing common chronic pain disorders.
- Recognize the roles of medical and conservative care in pain therapy that is evidence-based.
- Identify indications for referral to pain consultants by primary care providers.
- Assess indications and evaluate benefits of interventional therapies.
Faculty Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. Detailed disclosure will be made in the course handout materials.
|
